{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:59:07Z","timestamp":1790348347025,"version":"4.1.0"},"reference-count":48,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"unspecified","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Horphag Research, Av. Louis-Casa\u00ef, 1216 Cointrin, Switzerland.","award":["Not applicable."],"award-info":[{"award-number":["Not applicable."]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,9,10]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the distribution and day-to-day variability of EuroQol Visual Analogue Scale (EQ-VAS) values and to estimate a minimal important difference (MID) in adults with post-COVID-19 condition (PCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Secondary analysis of pooled EQ-VAS data from both arms of a 12-week randomised, placebo-controlled trial (PYCNOVID) of Pycnogenol (200 mg\/day) versus placebo in adults with PCC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Single centre study in Switzerland between June 2023 and July 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Adults with PCC with at least one of the following symptoms: fatigue, post-exertional malaise, dyspnoea or brain fog.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main outcome measure<\/jats:title>\n                    <jats:p>EQ-VAS ratings over 7 consecutive days before baseline (randomisation) and at follow-up (after 12 weeks). Weekly mean EQ-VAS values and within-person SDs (wpSD) were calculated. The MID was estimated using distribution-based and anchor-based methods with prespecified correlation criteria, using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) instrument as the primary anchor, along with additional anchors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 153 participants, baseline EQ-VAS values were low, with a median of 48.7 on a 0\u2013100\u2009scale. Day-to-day variability was considerable, with a median wpSD of 6.4. Distribution-based MID estimates ranged from 5.9 to 8.9 points. FACIT-Fatigue was the only anchor meeting the correlation threshold (\u03c1\u22650.30), yielding an anchor-based MID of 8.96 points. Triangulation of these estimates supported a final MID estimate of 8 EQ-VAS points.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Adults with PCC reported markedly impaired and highly variable health status. Weekly aggregation of daily EQ-VAS ratings likely provides a more robust estimate than single-day assessments. A PCC-specific EQ-VAS MID of 8 points, derived from a chronic, fatigue-predominant PCC population, facilitates interpretation of meaningful change and improves outcome definition and sample size planning in future studies. Applicability to earlier-stage or non-fatigue-predominant PCC populations warrants further investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05890534\">NCT05890534<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-121051","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:05:45Z","timestamp":1790345145000},"page":"e121051","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Within-person variability and the minimal important difference of the EQ-VAS in adults with post-COVID-19 condition: a secondary analysis of data from a single-centre randomised controlled trial"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct05890534","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7871-8707","authenticated-orcid":false,"given":"Julia","family":"Kopp","sequence":"first","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tala","family":"Ballouz","sequence":"additional","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5970-1846","authenticated-orcid":false,"given":"Dominik","family":"Menges","sequence":"additional","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7134-1000","authenticated-orcid":false,"given":"Anja","family":"Frei","sequence":"additional","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Braun","sequence":"additional","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Kuenzi","sequence":"additional","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo A","family":"Puhan","sequence":"additional","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan S","family":"Fehr","sequence":"additional","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1723-1070","authenticated-orcid":false,"given":"Thomas","family":"Radtke","sequence":"additional","affiliation":[{"name":"Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Z\u00fcrich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"2026092507052935000_16.9.e121051.1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5271\/sjweh.4088","article-title":"Post-COVID condition or \u201clong COVID\u201d, return-to work, and occupational health research","volume":"49","author":"Descatha","year":"2023","journal-title":"Scand J Work Environ Health"},{"key":"2026092507052935000_16.9.e121051.2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ajim.23735","article-title":"Burden of Selected Chronic Conditions Among Adults of Prime Working Age (25\u201354) by 2022 Self\u2010Reported COVID\u201019 and Long COVID History Compared to 2019 Pre\u2010Pandemic Baseline Prevalence: Behavioral Risk Factor Surveillance System","volume":"68","author":"Silver","year":"2025","journal-title":"American J Industrial Med"},{"key":"2026092507052935000_16.9.e121051.3","doi-asserted-by":"crossref","unstructured":"Wang J , Goodfellow H , Walker S , et al . Trajectories of functional limitations, health-related quality of life and societal costs in individuals with long COVID: a population-based longitudinal cohort study. BMJ Open 2024;14. doi:10.1136\/bmjopen-2024-088538","DOI":"10.1136\/bmjopen-2024-088538"},{"key":"2026092507052935000_16.9.e121051.4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310458","article-title":"Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges","volume":"24","author":"Tsilingiris","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026092507052935000_16.9.e121051.5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-34678-8","article-title":"Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19","volume":"13","author":"Malesevic","year":"2023","journal-title":"Sci Rep"},{"key":"2026092507052935000_16.9.e121051.6","doi-asserted-by":"crossref","unstructured":"Wong AW , Tran KC , Binka M , et al . Use of latent class analysis and patient reported outcome measures to identify distinct long COVID phenotypes: A longitudinal cohort study. PLoS One 2023;18. doi:10.1371\/journal.pone.0286588","DOI":"10.1371\/journal.pone.0286588"},{"key":"2026092507052935000_16.9.e121051.7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10198-013-0502-3","article-title":"The development of new research methods for the valuation of EQ-5D-5L","volume":"14","author":"Devlin","year":"2013","journal-title":"Eur J Health Econ"},{"key":"2026092507052935000_16.9.e121051.8","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207782"},{"key":"2026092507052935000_16.9.e121051.9","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0548-3"},{"key":"2026092507052935000_16.9.e121051.10","doi-asserted-by":"crossref","unstructured":"Hu M , Song T , Gong Z , et al . Symptom Trajectories and Clinical Subtypes in Post-COVID-19 Condition: Systematic Review and Clustering Analysis. JMIR Public Health Surveill 2025;11. doi:10.2196\/72221","DOI":"10.2196\/72221"},{"key":"2026092507052935000_16.9.e121051.11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/resp.14032","article-title":"Contemporary perspectives in COPD: Patient burden, the role of gender and trajectories of multimorbidity","volume":"26","author":"Buttery","year":"2021","journal-title":"Respirology"},{"key":"2026092507052935000_16.9.e121051.12","doi-asserted-by":"crossref","unstructured":"Greenwood DC , Mansoubi M , Bakerly ND , et al . Physical, cognitive, and social triggers of symptom fluctuations in people living with long COVID: an intensive longitudinal cohort study. Lancet Reg Health Eur 2024;46. doi:10.1016\/j.lanepe.2024.101082","DOI":"10.1016\/j.lanepe.2024.101082"},{"key":"2026092507052935000_16.9.e121051.13","doi-asserted-by":"crossref","unstructured":"Owen R , Ashton RE , Bewick T , et al . Profiling the persistent and episodic nature of long COVID symptoms and the impact on quality of life and functional status: a cohort observation study. J Glob Health 2025;15. doi:10.7189\/jogh.15.04006","DOI":"10.7189\/jogh.15.04006"},{"key":"2026092507052935000_16.9.e121051.14","unstructured":"Global Initiative for Chronic Obstructive Lung Disease . GLOBAL STRATEGY FOR PREVENTION, DIAGNOSIS AND MANAGEMENT OF COPD: 2025 Report. 2025. Available: https:\/\/goldcopd.org\/2025-gold-report\/ [accessed 3 Mar 2026]"},{"key":"2026092507052935000_16.9.e121051.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074425","article-title":"Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study","volume":"381","author":"Ballouz","year":"2023","journal-title":"BMJ"},{"key":"2026092507052935000_16.9.e121051.16","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092522","article-title":"Minimal Clinically Important Differences in EQ-5D-5L Index and VAS after a Respiratory Muscle Training Program in Individuals Experiencing Long-Term Post-COVID-19 Symptoms","volume":"11","author":"Del Corral","year":"2023","journal-title":"Biomedicines"},{"key":"2026092507052935000_16.9.e121051.17","doi-asserted-by":"crossref","unstructured":"Radtke T , K\u00fcnzi L , Kopp J , et al . Effects of Pycnogenol\u00ae in people with post-COVID-19 condition (PYCNOVID): study protocol for a single-center, placebo controlled, quadruple-blind, randomized trial. Trials 2024;25. doi:10.1186\/s13063-024-08187-6","DOI":"10.1186\/s13063-024-08187-6"},{"key":"2026092507052935000_16.9.e121051.18","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00703-9\/ATTACHMENT\/31179DEC-CF64-455B-BD13-6EF0045B7DD6\/MMC1.PDF"},{"key":"2026092507052935000_16.9.e121051.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2026092507052935000_16.9.e121051.20","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"2026092507052935000_16.9.e121051.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(96)00274-6"},{"key":"2026092507052935000_16.9.e121051.22","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jval.2018.03.013","article-title":"General Population Norms for the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale","volume":"21","author":"Montan","year":"2018","journal-title":"Value Health"},{"key":"2026092507052935000_16.9.e121051.23","article-title":"Proposed mid in facit and vas scores for individuals attending covid-19 rehabilitation","volume":"58","author":"Gerlis","year":"2021","journal-title":"Eur Respir J"},{"key":"2026092507052935000_16.9.e121051.24","doi-asserted-by":"crossref","unstructured":"Daynes E , Baldwin MM , Annals M , et al . Changes in fatigue symptoms following an exercise-based rehabilitation programme for patients with long COVID. ERJ Open Res 2024;10. doi:10.1183\/23120541.00089-2024","DOI":"10.1183\/23120541.00089-2024"},{"key":"2026092507052935000_16.9.e121051.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2003.10.013"},{"key":"2026092507052935000_16.9.e121051.26","doi-asserted-by":"publisher","DOI":"10.1136\/thx.42.10.773"},{"key":"2026092507052935000_16.9.e121051.27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2147\/COPD.S77368","article-title":"A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges","volume":"10","author":"Cazzola","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026092507052935000_16.9.e121051.28","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-6-46","article-title":"The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease","volume":"6","author":"Puhan","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"2026092507052935000_16.9.e121051.29","doi-asserted-by":"crossref","unstructured":"Smith AB , Greenwood DC , Milne R , et al . The EQ-5D-5L and Minimal Important Change in Long COVID. Adv Rehabil Sci Pract 2026;15. doi:10.1177\/27536351261423961","DOI":"10.1177\/27536351261423961"},{"key":"2026092507052935000_16.9.e121051.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.03.012"},{"key":"2026092507052935000_16.9.e121051.31","doi-asserted-by":"publisher","DOI":"10.1007\/s00586-024-08369-5"},{"key":"2026092507052935000_16.9.e121051.32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154587","article-title":"The Minimal Important Difference in Physical Activity in Patients with COPD","volume":"11","author":"Demeyer","year":"2016","journal-title":"PLoS ONE"},{"key":"2026092507052935000_16.9.e121051.33","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.12.954"},{"key":"2026092507052935000_16.9.e121051.34","doi-asserted-by":"crossref","unstructured":"Wu Y , Levis B , Sun Y , et al . Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ 2021;n972. doi:10.1136\/bmj.n972","DOI":"10.1136\/bmj.n972"},{"key":"2026092507052935000_16.9.e121051.35","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-021-02925-y"},{"key":"2026092507052935000_16.9.e121051.36","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e318184759e"},{"key":"2026092507052935000_16.9.e121051.37","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-018-0986-8","article-title":"Valuing health-related quality of life: systematic variation in health perception","volume":"16","author":"Huber","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"2026092507052935000_16.9.e121051.38","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.991572","article-title":"Health-related quality of life in persons post-COVID-19 infection in comparison to normative controls and chronic pain patients","volume":"10","author":"Moens","year":"2022","journal-title":"Front Public Health"},{"key":"2026092507052935000_16.9.e121051.39","doi-asserted-by":"crossref","DOI":"10.3389\/fepid.2023.1144162","article-title":"Cross-sectional and longitudinal comparison of health-related quality of life and mental well-being between persons with and without post COVID-19 condition","volume":"3","author":"Scott","year":"2023","journal-title":"Front Epidemiol"},{"key":"2026092507052935000_16.9.e121051.40","doi-asserted-by":"publisher","DOI":"10.1002\/JMV.27309"},{"key":"2026092507052935000_16.9.e121051.41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280343","article-title":"Within and between-day variation and associations of symptoms in Long Covid: Intensive longitudinal study","volume":"18","author":"Burton","year":"2023","journal-title":"PLoS One"},{"key":"2026092507052935000_16.9.e121051.42","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13071908","article-title":"Long COVID Clinical Severity Types Based on Symptoms and Functional Disability: A Longitudinal Evaluation","volume":"13","author":"Sivan","year":"2024","journal-title":"J Clin Med"},{"key":"2026092507052935000_16.9.e121051.43","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.03272"},{"key":"2026092507052935000_16.9.e121051.44","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-069217","article-title":"Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: a cross-sectional observational study","volume":"13","author":"Walker","year":"2023","journal-title":"BMJ Open"},{"key":"2026092507052935000_16.9.e121051.45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-048391","article-title":"Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study","volume":"11","author":"Dennis","year":"2021","journal-title":"BMJ Open"},{"key":"2026092507052935000_16.9.e121051.46","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jval.2021.05.001","article-title":"Good Days and Bad Days: Measuring Health-Related Quality of Life in People With Epilepsy","volume":"24","author":"Wester","year":"2021","journal-title":"Value Health"},{"key":"2026092507052935000_16.9.e121051.47","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.55430","article-title":"Sex Differences in Long COVID","volume":"8","author":"Shah","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026092507052935000_16.9.e121051.48","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jamainternmed.2023.0750","article-title":"Risk Factors Associated With Post\u2212COVID-19 Condition","volume":"183","author":"Tsampasian","year":"2023","journal-title":"JAMA Intern Med"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-121051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:05:52Z","timestamp":1790345152000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-121051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,25]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjopen-2026-121051"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-121051","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}